Enara Health, a developer of a technology-powered personalised weight loss programme, is expanding telehealth availability of its programme to all residents in California, Texas and Illinois. This rollout represents an earlier-than-planned first stage of a US rollout of the Enara Health platform, a clinical weight loss programme that takes a multi-faceted approach to obesity treatment.
Researchers from the CNRS, Inrae, University of Burgundy, Université de Paris, Inserm and University of Luxembourg have just revealed the mechanisms in the brain that lead to feelings of satiety after eating – and involve a series of reactions triggered by a rise in blood glucose levels. The study, ‘Postprandial Hyperglycemia Stimulates Neuroglial Plasticity in Hypothalamic POMC Neurons after a Balanced Meal’, which was conducted on mice, was published in Cell Reports.
Coinciding with World Obesity Day, over 100 medical and scientific organisations have pledged their support for a consensus statement that recognises unscientific public narratives of obesity as a major cause of weight stigma and calls for strong policies and legislation to prevent weight-based discrimination.
There is a clear relationship between obesity and the severity of COVID-19 disease, according to research presented by François Pattou, Professor of Surgery at the Faculty of Medicine of the University of Lille, and head of the Department of General and Endocrine Surgery at Lille University Hospital, France, at this year's European and International Congress on Obesity.
A study of obesity among the largest Latino populations living in New York City (NYC) has reported that the prevalence of obesity varies widely with Mexicans and Puerto Ricans much more likely to have obesity than Dominicans, Ecuadorians and Colombians.
Biomedical engineers at Duke University have shown that the efficacy of a two-pronged type 2 diabetes treatment increases when the drugs are linked by a heat-sensitive tether rather than simply concurrently administered. The combination molecule is formed by an elastin-like polypeptide (ELP) linker that forms a gel-like depot when injected under the skin, which slowly dissolves and releases the active drug over time.
Expectant mothers with obesity may hinder the development of the babies' brains as early as the second trimester, according to a new study led by researchers at NYU Grossman School of Medicine. The study linked high body mass index (BMI) to changes in two brain areas, the prefrontal cortex and anterior insula. These regions play a key role in decision-making and behaviour, with disruptions having previously been linked to attention-deficit/hyperactivity disorder (ADHD), autism and overeating.
As a person's weight increases all regions of the brain go down in activity and blood flow, according to a brain imaging study, ‘Patterns of Regional Cerebral Blood Flow as a Function of Obesity in Adults’, published in the Journal of Alzheimer's Disease.
Twenty-nine leading international partners have joined forces to establish a research consortium Stratification of Obese Phenotypes to Optimize Future Obesity Therapy (SOPHIA) with the aim of improving risk assessment of comorbidities and treatment for people with obesity. Obesity complications are common, but predicting who will develop any of the 200 known complications of obesity is extremely difficult. Moreover, there are insufficient predictors for who will respond to obesity treatments.
The childhood obesity rate may increase 2.4% or 1.27 million children if school closures to prevent the spread of the coronavirus continue into December, according to the study, ‘Projecting the impact of COVID-19 pandemic on childhood obesity in the U.S.: A microsimulation model’, published in the Journal of Sport and Health Science.